Hasil Pencarian - Jan Vesterbacka

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers

    Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers oleh Jan Vesterbacka, Javier Rivera, Kajsa Noyan, Mariona Parera, Ujjwal Neogi, Malu Calle, Roger Paredes, Anders Sönnerborg, Marc Noguera-Julian, Piotr Nowak

    Diterbitkan 2017-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy.

    Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy. oleh Jan Vesterbacka, Piotr Nowak, Babilonia Barqasho, Samir Abdurahman, Jessica Nyström, Staffan Nilsson, Hiroyuki Funaoka, Tatsuo Kanda, Lars-Magnus Andersson, Magnus Gisslèn, Anders Sönnerborg

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling

    Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling oleh Sara Svensson Akusjärvi, Anoop T. Ambikan, Shuba Krishnan, Soham Gupta, Maike Sperk, Ákos Végvári, Flora Mikaeloff, Katie Healy, Jan Vesterbacka, Piotr Nowak, Anders Sönnerborg, Ujjwal Neogi

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV

    Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV oleh Aswathy Narayanan, Oscar Kieri, Jan Vesterbacka, Lokeshwaran Manoharan, Puran Chen, Mahin Ghorbani, Hans-Gustaf Ljunggren, Margaret Sällberg Chen, Soo Aleman, Anders Sönnerborg, Shilpa Ray, Piotr Nowak

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals

    Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals oleh Sara Svensson Akusjärvi, Shuba Krishnan, Bianca B. Jütte, Anoop T. Ambikan, Soham Gupta, Jimmy Esneider Rodriguez, Ákos Végvári, Maike Sperk, Piotr Nowak, Jan Vesterbacka, J. Peter Svensson, Anders Sönnerborg, Ujjwal Neogi

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV

    Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV oleh Shilpa Ray, Aswathy Narayanan, Jan Vesterbacka, Ola Blennow, Puran Chen, Yu Gao, Giorgio Gabarrini, Hans-Gustaf Ljunggren, Marcus Buggert, Lokeshwaran Manoharan, Margaret Sällberg Chen, Soo Aleman, Anders Sönnerborg, Piotr Nowak

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDResearch in context

    Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDResear... oleh Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Söderdahl, Anders Österborg, C.I. Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael Åberg, Karin Loré, Margaret Sällberg Chen, Marcus Buggert, Per Ljungman, Soo Aleman, Hans-Gustaf Ljunggren

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine

    MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine oleh Caroline Boulouis, Tobias Kammann, Angelica Cuapio, Tiphaine Parrot, Yu Gao, Elli Mouchtaridi, David Wullimann, Joshua Lange, Puran Chen, Mira Akber, Olga Rivera Ballesteros, Jagadeeswara Rao Muvva, COVAXID study group, C. I. Edvard Smith, Jan Vesterbacka, Oscar Kieri, Piotr Nowak, Peter Bergman, Marcus Buggert, Hans-Gustaf Ljunggren, Soo Aleman, Johan K. Sandberg

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial

    Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial oleh Jonas Sundén-Cullberg, Puran Chen, Henrike Häbel, Paul Skorup, Helena Janols, Johan Rasmuson, Katarina Niward, Åse Östholm Balkhed, Katerina Chatzidionysiou, Hilmir Asgeirsson, Ola Blennow, Åsa Parke, Anna-Karin Svensson, Jagadeeswara Rao Muvva, Hans-Gustav Ljunggren, Anna-Carin Horne, Ulrika Ådén, Jan-Inge Henter, Anders Sönnerborg, Jan Vesterbacka, Piotr Nowak, Jon Lampa

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

    Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial oleh Peter Bergman, MD, Ola Blennow, MD, Lotta Hansson, MD, Stephan Mielke, MD, Piotr Nowak, MD, Puran Chen, MD, Gunnar Söderdahl, MD, Anders Österborg, MD, C. I. Edvard Smith, MD, David Wullimann, MSc, Jan Vesterbacka, MD, Gustaf Lindgren, MD, Lisa Blixt, MD, Gustav Friman, MD, Emilie Wahren-Borgström, MD, Anna Nordlander, MD, Angelica Cuapio Gomez, MD, Mira Akber, MSc, Davide Valentini, MD, Anna-Carin Norlin, MD, Anders Thalme, MD, Gordana Bogdanovic, MD, Sandra Muschiol, PhD, Peter Nilsson, PhD, Sophia Hober, PhD, Karin Loré, PhD, Margaret Sällberg Chen, PhD, Marcus Buggert, PhD, Hans-Gustaf Ljunggren, MD, Per Ljungman, MD, Soo Aleman, MD

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: